125 related articles for article (PubMed ID: 20060545)
41. Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects.
Kielstein JT; Bode-Böger SM; Frölich JC; Ritz E; Haller H; Fliser D
Circulation; 2003 Apr; 107(14):1891-5. PubMed ID: 12681993
[TBL] [Abstract][Full Text] [Related]
42. Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension.
Perticone F; Sciacqua A; Maio R; Perticone M; Maas R; Boger RH; Tripepi G; Sesti G; Zoccali C
J Am Coll Cardiol; 2005 Aug; 46(3):518-23. PubMed ID: 16053968
[TBL] [Abstract][Full Text] [Related]
43. Increased plasma levels of total homocysteine but not asymmetric dimethylarginine in Hispanic subjects with ischemic stroke FREC-VI sub-study.
Rueda-Clausen CF; Córdoba-Porras A; Bedoya G; Silva FA; Zarruk JG; López-Jaramillo P; Villa LA
Eur J Neurol; 2012 Mar; 19(3):417-25. PubMed ID: 21978129
[TBL] [Abstract][Full Text] [Related]
44. Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension.
Kielstein JT; Bode-Böger SM; Hesse G; Martens-Lobenhoffer J; Takacs A; Fliser D; Hoeper MM
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1414-8. PubMed ID: 15860741
[TBL] [Abstract][Full Text] [Related]
45. Associations between serum L-arginine and ficolins in the early phase of acute ischemic stroke - A pilot study.
Molnar T; Csuka D; Pusch G; Nagy L; Garred P; Illes Z
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104951. PubMed ID: 32689592
[TBL] [Abstract][Full Text] [Related]
46. Asymmetric dimethyarginine as marker and mediator in ischemic stroke.
Chen S; Li N; Deb-Chatterji M; Dong Q; Kielstein JT; Weissenborn K; Worthmann H
Int J Mol Sci; 2012 Nov; 13(12):15983-6004. PubMed ID: 23443106
[TBL] [Abstract][Full Text] [Related]
47. The asymmetric dimethylarginine level is associated with the predicted stroke risk in Japanese women.
Muraga K; Nishiyama Y; Otsuka T; Ueda M; Abe A; Katayama Y
J Atheroscler Thromb; 2014; 21(7):640-7. PubMed ID: 24463840
[TBL] [Abstract][Full Text] [Related]
48. Are increased oxidative stress and asymmetric dimethylarginine levels associated with masked hypertension?
Inan B; Ates I; Ozkayar N; Kundi H; Topcuoglu C; Dede F; Sennaroglu E
Clin Exp Hypertens; 2016; 38(3):294-8. PubMed ID: 27018581
[TBL] [Abstract][Full Text] [Related]
49. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
[TBL] [Abstract][Full Text] [Related]
50. Asymmetric dimethylarginine, vascular calcifications and parathyroid hormone serum levels in hemodialysis patients.
Coen G; Mantella D; Sardella D; Beraldi MP; Ferrari I; Pierantozzi A; Lippi B; Di Giulio S
J Nephrol; 2009; 22(5):616-22. PubMed ID: 19809994
[TBL] [Abstract][Full Text] [Related]
51. [Asymmetric dimethylarginine--a novel cardiovascular risk factor].
Siroká R; Cibulka R; Rajdl D; Racek J
Vnitr Lek; 2006 Mar; 52(3):249-55. PubMed ID: 16722156
[TBL] [Abstract][Full Text] [Related]
52. Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine.
Böger GI; Rudolph TK; Maas R; Schwedhelm E; Dumbadze E; Bierend A; Benndorf RA; Böger RH
J Am Coll Cardiol; 2007 Jun; 49(23):2274-82. PubMed ID: 17560293
[TBL] [Abstract][Full Text] [Related]
53. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study.
Schnabel R; Blankenberg S; Lubos E; Lackner KJ; Rupprecht HJ; Espinola-Klein C; Jachmann N; Post F; Peetz D; Bickel C; Cambien F; Tiret L; Münzel T
Circ Res; 2005 Sep; 97(5):e53-9. PubMed ID: 16100045
[TBL] [Abstract][Full Text] [Related]
54. Correlates of arterial stiffness in an ageing population: role of asymmetric dimethylarginine.
Ngo DT; Sverdlov AL; McNeil JJ; Horowitz JD
Pharmacol Res; 2009 Dec; 60(6):503-7. PubMed ID: 19559793
[TBL] [Abstract][Full Text] [Related]
55. ADMA--a Possible Marker for Early Therapeutic Outcome in Acute Stroke.
Petrova JJ; Manolov VE; Vasilev VG; Zlatareva DK; Tzatchev KN
Clin Lab; 2015; 61(11):1653-8. PubMed ID: 26731989
[TBL] [Abstract][Full Text] [Related]
56. [The relationship between serum asymmetric dimethylarginine and ABCD2 score in transient ischemic attack patients].
Zhang Y; Fan D; Zhang N
Zhonghua Nei Ke Za Zhi; 2014 Nov; 53(11):876-9. PubMed ID: 25586358
[TBL] [Abstract][Full Text] [Related]
57. Predictors of asymmetric dimethylarginine levels in patients with rheumatoid arthritis: the role of insulin resistance.
Dimitroulas T; Sandoo A; Veldhuijzen van Zanten JJ; Smith JP; Hodson J; Metsios GS; Stavropoulos-Kalinoglou A; Kitas GD
Scand J Rheumatol; 2013; 42(3):176-81. PubMed ID: 23311682
[TBL] [Abstract][Full Text] [Related]
58. [THE CLINICAL LABORATORY MARKERS OF ATHEROSCLEROSIS IN PATIENTS WITH ATHEROTHROMBOTIC STROKE].
Solovyeva LN; Shmonin AA; Emanuel YV; Stolyarov MS; Bondareva EA; Mazing A V ; Lazareva NM; Kholopova IV; Blinova TV; Kharitonova TV; Lapin SV; Emanuel VL; Melnikova EV
Klin Lab Diagn; 2015 Oct; 60(10):12-6. PubMed ID: 26841665
[TBL] [Abstract][Full Text] [Related]
59. Clinical Utility of the Inflammatory Factors Combined With Lipid Markers in the Diagnostic and Prognostic Assessment of Ischemic Stroke: Based on Logistic Regression Models.
Ma Z; Yue Y; Luo Y; Wang W; Cao Y; Fang Q
J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104653. PubMed ID: 32033900
[TBL] [Abstract][Full Text] [Related]
60. Analysis of the Usefulness of the WORSEN Score for Predicting the Deterioration of Acute Ischemic Stroke.
Miyamoto N; Tanaka R; Ueno Y; Watanabe M; Kurita N; Hira K; Shimada Y; Kuroki T; Yamashiro K; Urabe T; Hattori N
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2834-2839. PubMed ID: 28784279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
